Protocol Ledger

NCT05149807 · Phase II/III · TERMINATED

Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer

Interventional Phase II/III clinical trial protocol NCT05149807 sponsored by Suzhou Suncadia Biopharmaceuticals Co in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-01-26 Enrollment: 81 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05149807
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)81 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05149807
Protocol FieldVerified Registry Value
NCT IdentifierNCT05149807
Consolidated Lead SponsorSuzhou Suncadia Biopharmaceuticals Co
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II/III
Overall Recruitment StatusTERMINATED
Registered Enrollment81 participants (ACTUAL)
Registered Start Date2022-01-26
WhyStopped ClassificationUnspecified

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI